Menú

VERTAP
Grup de recerca en abordatge del vertigen en Atenció Primària (VERTAP)

Responsable del grupo
MARCEVAP - Josep_Lluis_Ballve
José Luis Ballvé Moreno
ballvejl@gmail.com
avatar_grups_recerca.png

Publicaciones

Efficacy of an electronic reminder for HIV screening in primary healthcare based on indicator conditions in Catalonia (Spain)

C. AGUSTI, O. CUNILLERA, J. ALMEDA, J. MASCORT, R. CARRILLO, C. OLMOS, A. MONTOLIU, M. ALBERNY, I. MOLINA, L. CAYUELAS and J. CASABONA
HIV MEDICINE. 2022 Sep 1; . doi:10.1111/hiv.13270; PMID:35285143

Ver más:
Trends in glycemic control, cardiovascular risk factors and chronic complications of type 2 diabetes, 2012-2016, in a healthcare area of Barcelona

I. LOPEZ-COBO, L. RODRIGUEZ-LATRE, O. CUNILLERA, I. RUIZ, S. COPETTI, M. ALBAREDA and L. VILA
DIABETES RESEARCH AND CLINICAL PRACTICE. 2022 Aug 1; . doi:10.1016/j.diabres.2022.110014; PMID:35870572

Ver más:
Effectiveness of a training intervention to improve the management of vertigo in primary care: a multicentre cluster-randomised trial, VERTAP

J. PATINO, J. MORENO, Y. MATOS, J. ORTEGA, O. PUERTOLAS, R. MUNOZ, I. BALBOA, X. COMPTA, O. AGUDELO, S. MUNOZ, V. RODRIGUEZ, A. CORTES and E. RODRIGUEZ
Trials. 2022 Jul 29; . doi:10.1186/s13063-022-06548-7; PMID:35906606

Ver más:
Montelukast and COVID-19-related complications in people with SARS-CoV-2 infection: A population-based observational study

F. CORDERO, S. MONNE, J. ORTEGA, S. CONTRERAS-MARTOS, D. OUCHI, M. GINER-SORIANO, R. PEDROS and B. GONZALEZ
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2022 May 1;

Ver más:
Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-speranza COVID-19 Project study protocol

S. MONNE, F. CORDERO, G. MUNOZ, J. ORTEGA, S. MARTOS, O. PUERTOLAS, A. SANGENIS, R. PEDROS, R. PEDROS and M. GONZALEZ
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2022 May 1;

Ver más: